Gryphon Financial Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
6,609
-5,530
-46% -$300K 0.02% 315
2026
Q1
$762K Buy
12,139
+599
+5% +$47.9K 0.08% 169
2025
Q4
$1.1M Buy
11,540
+176
+2% +$17.3K 0.12% 116
2025
Q3
$1.11M Buy
11,364
+3,021
+36% +$313K 0.13% 107
2025
Q2
$896K Buy
8,343
+3,656
+78% +$370K 0.12% 117
2025
Q1
$473K Buy
4,687
+332
+8% +$33.4K 0.07% 175
2024
Q4
$389K Buy
4,355
+166
+4% +$14.6K 0.06% 180
2024
Q3
$351K Buy
4,189
+461
+12% +$36.3K 0.05% 207
2024
Q2
$287K Sell
3,728
-326
-8% -$23.9K 0.04% 227
2024
Q1
$278K Buy
4,054
+225
+6% +$14.5K 0.05% 214
2023
Q4
$221K Sell
3,829
-40
-1% -$2.13K 0.04% 215
2023
Q3
$204K Buy
3,869
+67
+2% +$3.51K 0.05% 176
2023
Q2
$206K Buy
+3,802
New +$199K 0.04% 187
2018
Q3
Sell
-2,284
Closed -$75K 247
2018
Q2
$75K Sell
2,284
-8
-0.3% -$241 0.03% 161
2018
Q1
$62K Sell
2,292
-29
-1% -$788 0.03% 192
2017
Q4
$57K Buy
+2,321
New +$64K 0.03% 223

Other funds holding BSX

Gryphon Financial Partners's BSX Position: Q2 2026 in Review

Gryphon Financial Partners reduced its Boston Scientific (BSX) stake by 46% in Q2 2026, selling an estimated $300K and leaving 6,609 shares worth $282K. The position accounts for 0.02% of the portfolio, ranked #315.

Gryphon Financial Partners first reported a position in BSX in Q4 2017 and has held it in 16 quarters since. The position peaked at $1.11M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gryphon Financial Partners held 6,609 shares of Boston Scientific worth $282K as of Q2 2026.
  • Gryphon Financial Partners sold 5,530 Boston Scientific shares in Q2 2026, an estimated $300K.
  • Boston Scientific made up 0.02% of Gryphon Financial Partners's portfolio in Q2 2026, its #315 holding.
  • Gryphon Financial Partners first reported a position in Boston Scientific in Q4 2017 and has held it in 16 quarters since.
  • Gryphon Financial Partners's Boston Scientific position peaked at $1.11M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.